<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Integrated Preclinical Imaging

From high content cellular imaging to in vivo bioluminescent models and spatial biology, Crown Bioscience delivers imaging technologies that connect mechanism, response, and translation across drug discovery and development.

Imaging Across Biological Scales

Our imaging technologies span cells, tissues, and in vivo models, enabling quantitative insight from early discovery through translational research.

3d imaging-Teal
High-Content Imaging

Automated, multiparametric high content imaging enables quantitative assessment of cellular phenotypes, target engagement, and mechanism of action across 2D and 3D in vitro models, supporting scalable screening and hypothesis driven studies.

icon-mouse
In Vivo Imaging Models

Orthotopic and bioluminescent tumor models enable non-invasive, longitudinal monitoring of tumor growth, metastasis, and treatment response, providing clinically relevant insight into disease progression and therapeutic efficacy.

Spatial Multiomics Services
Spatial Biology & Pathology

Integrated spatial biology and digital pathology workflows preserve tissue context while enabling high-resolution molecular and histological analysis, supporting biomarker discovery, mechanism of action, and translational insight.

proteomics
Nanostring Spatial Profiling

Nanostring GeoMx spatial transcriptomics and proteomics enable region-specific molecular profiling within complex tissues, supporting immune characterization, target validation, and patient-relevant biomarker strategies.

Ready to De-risk Your Next Candidate?

Partner with Crown Bioscience's Integrated Preclinical Imaging scientists to design an efficient, regulatory-focused strategy for your drug discovery program.